Global Patent Index - EP 0472663 A4

EP 0472663 A4 19920701 - METHOD OF TREATMENT OF HEPATITIS

Title (en)

METHOD OF TREATMENT OF HEPATITIS

Publication

EP 0472663 A4 19920701 (EN)

Application

EP 90909416 A 19900515

Priority

US 35150289 A 19890515

Abstract (en)

[origin: WO9014091A1] Hepatitis B is treated by administering an effective amount of 2',3'-dideoxyguanosine, 2',3'-dideoxyadenosine, or 2',3'-dideoxyinosine.

IPC 1-7

A61K 31/70

IPC 8 full level

C07D 473/34 (2006.01); A61K 31/495 (2006.01); A61K 31/52 (2006.01); A61K 31/70 (2006.01); A61P 1/16 (2006.01); C07D 405/04 (2006.01)

CPC (source: EP US)

A61K 31/70 (2013.01 - EP US); A61P 1/16 (2017.12 - EP)

Citation (search report)

  • [X] EP 0302760 B1 19920729 - UNIV ALBERTA [CA]
  • [X] EP 0216510 A2 19870401 - US COMMERCE [US]
  • [X] EP 0307914 A2 19890322 - HOFFMANN LA ROCHE [CH]
  • [X] BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 156, no. 3, 15th November 1988, pages 1144-1155, Academic Press, Inc.; S. SUZUKI et al.: "Inhibition of duck hepatitis B virus replication by purine 2',3'-dideoxynucleosides"
  • [X] LAB. INVEST., vol. 60, no. 1, January 1989, page 71A, abstract no. 420; K.L. PAUW et al.: "Histological effects of 2',3'-dideoxypurines in duck hepatitis B virus infection"
  • [X] ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 33, no. 3, March 1989, pages 336-339, American Society for Microbiology; B. LEE et al.: "In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus"
  • [X] HEPATOLOGY, vol. 8, no. 5, 1988, page 1329, abstract no. 444; P. MARTIN et al.: "Effects of 2',3'-dideoxyadenosine on duck hepatitis B virus"
  • [X] GASTROENTEROLOGY, vol. 96, no. 5, part 2, 13th 19th May 1989, page A628, Washington, DC, US; P. MARTIN et al.: "2',3'-Dideoxyinosine(DD1) and dideoxyguanosine (DD3) are potent inhibitors of hepadnaviruses in vivo"
  • [XP] ANTIVIRAL RESEARCH, vol. 12, nos. 5-6, 1989, pages 301-310, Elsevier Science Publishers B.V. (Biomedical Division); B. LÖFGREN et al.: "Inhibition of RNA- and DNA-dependent duck hepatitis B virus DNA polymerase activity by nucleoside and pyrophosphate analogs"
  • See references of WO 9014091A1

Designated contracting state (EPC)

AT BE CH DE DK ES FR GB IT LI LU NL SE

DOCDB simple family (publication)

WO 9014091 A1 19901129; AU 5832990 A 19901218; CA 2054771 A1 19901116; EP 0472663 A1 19920304; EP 0472663 A4 19920701; JP H04501857 A 19920402; US 5070077 A 19911203

DOCDB simple family (application)

US 9002686 W 19900515; AU 5832990 A 19900515; CA 2054771 A 19900515; EP 90909416 A 19900515; JP 50872890 A 19900515; US 35150289 A 19890515